BIOTECHNOLOGY AND LIFE SCIENCES products beginning with : A
5601 to 5650 of 9097 results Page: 
100 101 102 103 104 105 106 107 108 109 110 111 112 [113] 114 115 116 117 118 119 120 
100 101 102 103 104 105 106 107 108 109 110 111 112 [113] 114 115 116 117 118 119 120
Anti-Ifnb1 Neutralizing Antibody (V3S-0822-YC1354) (1 supplier)
Anti-IFNG (Crenezumab)-MC-MMAF ADC (1 supplier)
Anti-IFNG (Crenezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IFNG (Crenezumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IFNG (Crenezumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IFNG (Crenezumab)-SMCC-DM1 ADC (1 supplier)
Anti-IFNG (Crenezumab)-SPDB-DM4 ADC (1 supplier)
Anti-Ifng Neutralizing Antibody (V3S-0822-YC1384) (1 supplier)
Anti-IFNGR1 (ECD domain) Neutralizing Antibody (V3S-0822-YC1405) (1 supplier)
Anti-IFNL2 (aa 20-193) Neutralizing Antibody (V3S-0822-YC1416) (1 supplier)
Anti-IgE (CemX domain) Neutralizing Antibody (V3S-0522-YC8154) (1 supplier)
Anti-IgE Antibody (4 suppliers)
Anti-IgE Aptamer (1 supplier)
Anti-IgE Fc (Talizumab)-MC-MMAF ADC (1 supplier)
Anti-IgE Fc (Talizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IgE Fc (Talizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IgE Fc (Talizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IgE Fc (Talizumab)-SMCC-DM1 ADC (1 supplier)
Anti-IgE Fc (Talizumab)-SPDB-DM4 ADC (1 supplier)
Anti-IgE Fc Neutralizing Antibody (V3S-0622-YC4570) (1 supplier)
Anti-IgE Neutralizing Antibody (V3S-0522-YC7466) (1 supplier)
Anti-IgE(human) Aptamer (1 supplier)
Anti-IGF1 (Ganitumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1 (Ganitumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1 (Ganitumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1 (Ganitumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1 (Ganitumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGF1 (Ganitumab)-SPDB-DM4 ADC (1 supplier)
Anti-IGF1 Neutralizing Antibody (V3S-0622-YC256) (1 supplier)
Anti-IGF1-MC-MMAF ADC (1 supplier)
Anti-IGF1-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1-SMCC-DM1 ADC (1 supplier)
Anti-IGF1-SPDB-DM4 ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-SPDB-DM4 ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-SPDB-DM4 ADC (1 supplier)
Anti-IGF1R (ECD domain) Neutralizing Antibody (V3S-0622-YC259) (1 supplier)
Anti-IGF1R (Figitumumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1R (Figitumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IFNG (Crenezumab)-MC-MMAF ADC (1 supplier)
Anti-IFNG (Crenezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IFNG (Crenezumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IFNG (Crenezumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IFNG (Crenezumab)-SMCC-DM1 ADC (1 supplier)
Anti-IFNG (Crenezumab)-SPDB-DM4 ADC (1 supplier)
Anti-Ifng Neutralizing Antibody (V3S-0822-YC1384) (1 supplier)
Anti-IFNGR1 (ECD domain) Neutralizing Antibody (V3S-0822-YC1405) (1 supplier)
Anti-IFNL2 (aa 20-193) Neutralizing Antibody (V3S-0822-YC1416) (1 supplier)
Anti-IgE (CemX domain) Neutralizing Antibody (V3S-0522-YC8154) (1 supplier)
Anti-IgE Antibody (4 suppliers)
Anti-IgE Aptamer (1 supplier)
Anti-IgE Fc (Talizumab)-MC-MMAF ADC (1 supplier)
Anti-IgE Fc (Talizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IgE Fc (Talizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IgE Fc (Talizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IgE Fc (Talizumab)-SMCC-DM1 ADC (1 supplier)
Anti-IgE Fc (Talizumab)-SPDB-DM4 ADC (1 supplier)
Anti-IgE Fc Neutralizing Antibody (V3S-0622-YC4570) (1 supplier)
Anti-IgE Neutralizing Antibody (V3S-0522-YC7466) (1 supplier)
Anti-IgE(human) Aptamer (1 supplier)
Anti-IGF1 (Ganitumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1 (Ganitumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1 (Ganitumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1 (Ganitumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1 (Ganitumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGF1 (Ganitumab)-SPDB-DM4 ADC (1 supplier)
Anti-IGF1 Neutralizing Antibody (V3S-0622-YC256) (1 supplier)
Anti-IGF1-MC-MMAF ADC (1 supplier)
Anti-IGF1-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1-SMCC-DM1 ADC (1 supplier)
Anti-IGF1-SPDB-DM4 ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGF1R (Cixutumumab)-SPDB-DM4 ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGF1R (Dalotuzumab)-SPDB-DM4 ADC (1 supplier)
Anti-IGF1R (ECD domain) Neutralizing Antibody (V3S-0622-YC259) (1 supplier)
Anti-IGF1R (Figitumumab)-MC-MMAF ADC (1 supplier)
Anti-IGF1R (Figitumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
